QPACU Stock News 10.70 05/13/2014 15:00:33 Quinpario Acquisition

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Quinpario Acquisition Corp (QPACU) 10.70 $QPACU

Quinpario Acquisition Corp. Announces Cash Tender Offer for Its Warrants
GlobeNewswire - Tue May 06, 3:24PM CDT
Quinpario Acquisition Corp. (Nasdaq:QPAC) (Nasdaq:QPACU) (Nasdaq:QPACW) ("Quinpario" today announced that it has commenced a tender offer to purchase up to 9,200,000 of its outstanding warrants at a purchase price of $0.75 per warrant, in cash, without interest, for an aggregate purchase price of up to $6,900,000.

Quinpario Acquisition Corp. and Jason Incorporated Receive U.S. Antitrust Clearance in Regard to Pending Acquisition
GlobeNewswire - Thu Apr 03, 4:38PM CDT
Quinpario Acquisition Corp. (Nasdaq:QPAC) (Nasdaq:QPACU) (Nasdaq:QPACW) ("Quinpario" and Jason Incorporated today announced that their request for early termination of the required waiting period with respect to filings made under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR Act", in connection with the previously announced proposed business combination has been granted. Quinpario announced a definitive agreement to acquire Jason Incorporated on March 17, 2014. The early termination of the HSR Act waiting period satisfies one of the conditions to the closing of the pending acquisition. The closing of the transaction is expected to be completed in the second quarter of 2014, pending shareholder approval, and remains subject to other customary closing conditions.

Quinpario Acquisition Corp. Receives Commitments to Purchase $45 Million of Preferred Stock
GlobeNewswire - Tue Apr 01, 6:49PM CDT
Quinpario Acquisition Corp. (Nasdaq:QPAC), (Nasdaq:QPACU), (Nasdaq:QPACW) ("Quinpario" today announced it has entered into commitment agreements with certain institutional investors pursuant to which such investors collectively agreed to purchase $45 million in shares of a newly authorized 8.0% Series A Convertible Perpetual Preferred Stock. Pursuant to the terms of the commitment letters, this investment is to be consummated simultaneously with the closing of the recently announced acquisition of Jason Incorporated, a parent company of a global family of diversified manufacturing companies. The proceeds from the sale of this preferred stock issuance may be used to help consummate the acquisition and to fund future organic and inorganic growth opportunities.

Quinpario Acquisition Corp. Announces Agreement to Acquire Jason Incorporated
GlobeNewswire - Mon Mar 17, 8:06AM CDT
Quinpario Acquisition Corp. (Nasdaq:QPAC) (Nasdaq:QPACU) (Nasdaq:QPACW) ("QPAC" today announced it has reached a definitive agreement to acquire Jason Incorporated ("Jason" or the "Company", from Saw Mill Capital LLC, Falcon Investment Advisors, LLC and other investors. Jason is a global family of market-leading manufacturing businesses within the finishing, seating, components and automotive acoustics markets. The purchase price of $538.65 million will be funded by the cash proceeds from QPAC's initial public offering, new debt and rollover equity invested by the current owners and management of Jason. The acquisition is expected to be completed in the second quarter of 2014, pending regulatory and shareholder approval, and satisfaction of customary closing conditions.

Quinpario Acquisition Corp. Closes $172,500,000 Initial Public Offering
PR Newswire - Wed Aug 14, 3:42PM CDT
Quinpario Acquisition Corp. (NASDAQ: QPACU), a special purpose acquisition company (SPAC) formed by Mr. Jeffry N. Quinn and Quinpario Partners LLC, today announced that it has completed its initial public offering of 17,250,000 units at $10.00 per unit, for gross proceeds to the company of $172,500,000, which includes the underwriters' exercise of their over-allotment option in full. The units are listed on the Nasdaq Capital Market under the symbol "QPACU". Each unit consists of one share of common stock and one warrant to purchase an additional share at a price of $12.00.

Quinpario Acquisition Corp. Announces Pricing of $150,000,000 Initial Public Offering
PR Newswire - Fri Aug 09, 7:30AM CDT
Quinpario Acquisition Corp. (the "Company" (QPACU), a newly-organized blank check company formed for the purpose of acquiring or merging with an operating business in the specialty chemicals and performance materials sectors, today announced the pricing of its initial public offering of 15,000,000 units at a price of $10.00 per unit for gross proceeds of $150,000,000 on August 8, 2013. Each unit issued in the initial public offering consists of one share of common stock and one warrant to purchase one share of common stock at an exercise price of $12.00 per share.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 49

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 273

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 79

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 290

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 133

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 189

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 103

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 21

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 675

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 188

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring AI's Impact on CRM Visibility and Brand Trust

Updated Category News Views 217

Understanding the Role of AI in CRM Visibility Brandi AI has recently launched its AI Visibility Index series, which offers insightful measurements of how industries are perceived in AI-generated responses. This new series highlights the ways in which customer relationship management (CRM) brands are represented through the lens of advanced AI answer engines. The AI...

Continue Reading
Celldex Therapeutics Thrives Amid Developments with Briquilimab

Updated Category News Views 148

Overview of Celldex Therapeutics and Briquilimab Celldex Therapeutics (NASDAQ: CLDX) is navigating an exciting phase as it explores treatments for chronic conditions like Chronic Inducible Urticaria (CIndU). Analysts have closely observed the efficacy of briquilimab, highlighting its performance through recent studies. Analyst Insights on Celldex and Briquilimab Goldman...

Continue Reading
XPENG's Financial Success in Q3 2024: Key Insights Revealed

Updated Category News Views 238

XPENG's Journey in the Third Quarter of 2024 XPeng Inc. (“XPENG” or “the Company,” NYSE: XPEV and HKEX: 9868) recently disclosed its financial results for the third quarter ended September 30, 2024. This marks a significant period showcasing growth in revenues and vehicle deliveries, reflecting the company's robust strategy in the smart electric vehicle market....

Continue Reading
Apple Inc. Beats Earnings Expectations: Analysts React

Updated Category News Views 144

Apple Inc. Overcomes Challenges with Strong Quarterly Results Apple Inc.‘s latest quarterly performance has generated significant buzz in the tech world. Analysts reveal that the results showcase a resilient company navigating through various market challenges. This performance not only reflects strong sales of products like the iPhone but also highlights impressive...

Continue Reading
Class Action Alert: Investors Have Rights with AMMO, Inc.

Updated Category News Views 237

Class Action Lawsuit Against AMMO, Inc. In a proactive move for investors, Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against AMMO, Inc. (NASDAQ: POWW). This suit comes in light of significant losses experienced by investors in the company due to alleged misstatements and omissions regarding its business practices. Understanding the Class...

Continue Reading